Jazz Pharmaceuticals plc buy Cantor Fitzgerald
Start price
10.04.24
/
50%
€106.15
Target price
10.04.25
€167.24
Performance (%)
-2.21%
Price
29.04.24
€103.80
Summary
This prediction is currently active. With a performance of -2.21%, the BUY prediction by Cantor_Fitzgerald is trending in the wrong direction. This prediction currently runs until 10.04.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Jazz Pharmaceuticals plc | 1.615% |
iShares Core DAX® | 0.961% |
iShares Nasdaq 100 | 2.626% |
iShares Nikkei 225® | 0.217% |
iShares S&P 500 | 1.540% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $180.00 price target on the stock.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€113.00
22.03.24
22.03.24
€166.54
22.03.25
22.03.25
-8.14%
29.04.24
29.04.24
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€109.90
29.02.24
29.02.24
€166.54
28.02.25
28.02.25
-5.55%
29.04.24
29.04.24